Tumor vasculature — Drug Target

All drugs that target Tumor vasculature — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Peptide

Phase 2 pipeline (1)

• EndoTAG-1 and Gemcitabine · MediGene · Peptide · Oncology
  EndoTAG-1 is a peptide that targets the tumor vasculature, while Gemcitabine is a nucleoside analog that interferes with DNA synthesis.